DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $576,036 | -42.1% | 2,490 | -37.9% | 0.02% | -50.0% |
| Q3 2023 | $995,129 | -0.8% | 4,011 | -4.0% | 0.04% | +2.7% |
| Q2 2023 | $1,002,720 | -21.9% | 4,178 | -18.0% | 0.04% | -26.0% |
| Q1 2023 | $1,283,639 | +153998.3% | 5,093 | +62.2% | 0.05% | +42.9% |
| Q4 2022 | $833 | -99.9% | 3,140 | +9.8% | 0.04% | +6.1% |
| Q3 2022 | $739,000 | +88.5% | 2,860 | +85.0% | 0.03% | +106.2% |
| Q2 2022 | $392,000 | -51.7% | 1,546 | -44.1% | 0.02% | -42.9% |
| Q1 2022 | $811,000 | -29.8% | 2,764 | -21.3% | 0.03% | -26.3% |
| Q4 2021 | $1,156,000 | -34.1% | 3,514 | -39.0% | 0.04% | -39.7% |
| Q3 2021 | $1,754,000 | +14.1% | 5,761 | +0.6% | 0.06% | +14.5% |
| Q2 2021 | $1,537,000 | +1.1% | 5,728 | -15.2% | 0.06% | -6.8% |
| Q1 2021 | $1,520,000 | +12.8% | 6,753 | +11.4% | 0.06% | +7.3% |
| Q4 2020 | $1,347,000 | +1.0% | 6,064 | -2.1% | 0.06% | -11.3% |
| Q3 2020 | $1,334,000 | +120.5% | 6,196 | +81.1% | 0.06% | +100.0% |
| Q2 2020 | $605,000 | +27.9% | 3,421 | +0.1% | 0.03% | +10.7% |
| Q1 2020 | $473,000 | +1.9% | 3,416 | +13.0% | 0.03% | +33.3% |
| Q4 2019 | $464,000 | -10.4% | 3,024 | -15.7% | 0.02% | -12.5% |
| Q3 2019 | $518,000 | -1.9% | 3,586 | -3.0% | 0.02% | -4.0% |
| Q2 2019 | $528,000 | +15.0% | 3,696 | +6.4% | 0.02% | +13.6% |
| Q1 2019 | $459,000 | +28.2% | 3,473 | +0.2% | 0.02% | +10.0% |
| Q4 2018 | $358,000 | -30.2% | 3,467 | -26.6% | 0.02% | -23.1% |
| Q3 2018 | $513,000 | +11.8% | 4,724 | +1.5% | 0.03% | -10.3% |
| Q2 2018 | $459,000 | -3.0% | 4,653 | -3.7% | 0.03% | -3.3% |
| Q1 2018 | $473,000 | +9.0% | 4,830 | +3.2% | 0.03% | +11.1% |
| Q4 2017 | $434,000 | +3.6% | 4,681 | -4.1% | 0.03% | -15.6% |
| Q3 2017 | $419,000 | -3.7% | 4,882 | -5.2% | 0.03% | -8.6% |
| Q2 2017 | $435,000 | +5.6% | 5,152 | +7.1% | 0.04% | +9.4% |
| Q1 2017 | $412,000 | +11.1% | 4,812 | +1.1% | 0.03% | +3.2% |
| Q4 2016 | $371,000 | +5.7% | 4,760 | +6.2% | 0.03% | -24.4% |
| Q3 2016 | $351,000 | -21.5% | 4,483 | +1.3% | 0.04% | -21.2% |
| Q2 2016 | $447,000 | +6.4% | 4,424 | 0.0% | 0.05% | +13.0% |
| Q1 2016 | $420,000 | +1.9% | 4,424 | -0.2% | 0.05% | +4.5% |
| Q4 2015 | $412,000 | +9.3% | 4,432 | +0.2% | 0.04% | +7.3% |
| Q3 2015 | $377,000 | -0.5% | 4,424 | 0.0% | 0.04% | +13.9% |
| Q2 2015 | $379,000 | +0.8% | 4,424 | 0.0% | 0.04% | +9.1% |
| Q1 2015 | $376,000 | -0.8% | 4,424 | 0.0% | 0.03% | -2.9% |
| Q4 2014 | $379,000 | +8.0% | 4,424 | -0.9% | 0.03% | +17.2% |
| Q2 2014 | $351,000 | +2.6% | 4,462 | +0.9% | 0.03% | -17.1% |
| Q4 2013 | $342,000 | +11.4% | 4,424 | 0.0% | 0.04% | +9.4% |
| Q3 2013 | $307,000 | +9.3% | 4,424 | 0.0% | 0.03% | -3.0% |
| Q2 2013 | $281,000 | – | 4,424 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |